Modular Finance IR Consensus: XVIVO Perfusion – Consensus estimates Q1 2026
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
Number of contributors: 7 (all of which have been updated or confirmed before the report)
| KPI (MSEK, unless otherwise specified) | Q1 2026E |
| Net sales | 232 |
| Organic growth in local currency (%) | 16.16 |
| Gross profit | 173 |
| EBITDA | 53.2 |
| EBIT | 35.2 |
| Net profit | 27.4 |
| Earnings per share (SEK) | 0.88 |
XVIVO Perfusion’s Q1 report will be released on Friday 24 April at 07.30 CEST.